Envoy Medical, Inc.
Envoy Medical, Inc. (Nasdaq: COCH) develops implantable medical technologies for people with hearing loss. Its investigational Acclaim cochlear implant is designed to be fully implanted, using a sensor in the middle ear to capture sound and an implanted processor and power source to stimulate the auditory nerve; it is… From the company’s description.
Over the twelve months to Sep 30, 2026, Envoy Medical, Inc. reported revenue of $0.23M, up 11.1% from a year earlier, and a net loss of $20.85M. Operations used $22.23M in cash. In fiscal 2025, it reported revenue of $0.24M, up 7.1% from fiscal 2024, and a net loss of $23.76M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Envoy Medical, Inc. does
In the company’s own words
Envoy Medical, Inc. (Nasdaq: COCH) develops implantable medical technologies for people with hearing loss. Its investigational Acclaim cochlear implant is designed to be fully implanted, using a sensor in the middle ear to capture sound and an implanted processor and power source to stimulate the auditory nerve; it is intended for adults with severe-to-profound sensorineural hearing loss who receive inadequate benefit from hearing aids. The company also has the FDA-approved Esteem fully implanted active middle ear implant, and is developing the Acclaim for potential commercialization subject to regulatory approval. Envoy Medical reports one operating and reportable segment. Its customers are expected to include patients, healthcare providers and institutions involved in cochlear implant care; the company plans to work with specialist surgeons and audiologists. The business shifted its development focus from Esteem to Acclaim in 2015, and became a public company through a business combination in 2023. The Acclaim pivotal study enrolled 56 patients, and the company had not yet received FDA approval to market it as of year-end 2025. Its website is www.envoymedical.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Medical Instruments
- Headquarters
- WHITE BEAR LAKE, MN
- Fiscal year end
- December
- CIK
- 1840877
- SIC
- 3842
Financial performance, year by year
Fiscal 2021–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Envoy Medical, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Envoy Medical, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Envoy Medical, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Envoy Medical, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Envoy Medical, Inc.'s last four quarterly filings that the numbers alone won't show?”